Archives by Month:
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Corvus Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
BURLINGAME, Calif., March 08, 2018 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and antibody agents that precisely target crucial enzymes and proteins in the immune system to treat patients with cancer, today announced the pricing of an underwritten public offering of 7,058,824 […]
HKMA Urges “Stay Calm” As Hong Kong Dollar Plunges To 30 Year Lows
On the same day as Hong Kong Monetary Authority (HKMA) Chief Norman Chan urged citizens to “stay calm on the currency weakening,” the Hong Kong Dollar has plunged to its weakest in 33 years amid liquidity concerns and a global carry trade gone rogue. The Hong Kong Dollar has been in free-fall for the last […]
What Tariffs Would Really Mean
Every day, you plunk out cash to support your neighbors. And they support you. That’s how economies work. I buy from my local store, which employs people, and I use local services. Even when I buy from Amazon, the stuff has to get here somehow. We also pay taxes, much of which goes to services that employ […]
With Trade Deficits Soaring: Who Will Buy US Treasuries?
“Will there be a mismatch between what the U.S. wants to sell (Treasuries) and what the world wants to buy?” Brad Setser asks the above question in his “Follow the Money” post How Will the U.S. Fund its Twin Deficits? In the past few years, the U.S. Treasury has needed to, on net, raise about three […]
3 Amigos Of The Macro, Updated
You thought I was done with the Amigos shtick, did you? Not by a long shot ma’am. They are the happy-go-lucky riders in play as the stock bull market churns on. They are the rising SPX/Gold ratio and stocks in general vs. gold (Amigo #1), rising US 10yr & 30yr yields (Amigo #2) and the […]
BTC/USD Technical Outlook: Bitcoin Prices Vulnerable To Deeper Losses
Bitcoin prices failed to break through the February highs with the breakdown now risking a deeper correction in the cryptocurrency. It’s important to note that the entire decline off the 2017 highs remains within the confines of the broader uptrend and although prices remain vulnerable for further losses near-term, the sell-off should ultimately offer more […]
Winners And Losers From Global Trade
In a grand effort to change the subject of the political discussion from Russia to something else, President Trump fired the opening shots in a new trade war. Not content to destroy the solar industry by adding costs without adding supply to solar panels, or making South Korean washing machines more expensive without making American […]
Track Sector Rotation For Better Returns
There are several decisions that must be made prior to entering a trade or investment. One must first decide what to invest in. Then the choice of when to invest comes and finally where to exactly enter. Most people decide what to invest in due to a recommendation from a broker, a friend, or even […]
Tesla Shares Slides After Sudden Departure Of Accounting Chief
It appears Elon Musk and his company’s management dug deep in their emotional baggage to write the press release explaining the sudden departure of their chief accounting officer… On March 7, 2018, Eric Branderiz left Tesla for personal reasons. Tesla appreciates Eric’s service to the company. And for now shareholders appear a little nervous…
Global Blood Therapeutics Announces Proposed Public Offering Of Common Stock
SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (Nasdaq:GBT), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need, today announced a registered offering of 3,500,000 shares of its common stock.The offering is expected to close on or […]
